(Q58855365)

English

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A J Manolis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B Jelakovic

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Jacovides

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D C Bernhardi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W J Cabrera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L A Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Barragan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Matadamas

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Mendiola

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K S Woo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J R Zhu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A D Mejia

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Bunt

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Dumortier

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R D Smith

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1186-1203

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Clinical Experience With Angiotensin II Receptor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure effects of the angiotensin II receptor blocker, losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor subtypes: selective antagonists and functional correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan vs losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II antagonists for hypertension: are there differences in efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesar

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum uric acid and cardiovascular events in successfully treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the renal effects of angiotensin II receptor blockade: The confounding factor of acute water loading on the action of vasoactive systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983062-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)83062-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110230%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58855365&oldid=1628115358"